35 reports

  • III. PRESCRIPTION DRUGS INDUSTRY ASSESSMENTS
  • V. PRESCRIPTION DRUGS MARKET OUTLOOK

After twenty years' rapid development, China' s prescription drugs market has become one of the largest prescription drugs markets in the world.

  • Prescription Drug
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • III. PRESCRIPTION DRUGS INDUSTRY ASSESSMENTS
  • III. PRESCRIPTION DRUGS INDUSTRY ASSESSMENTS

After twenty years' rapid development, China' s prescription drugs market has become one of the largest prescription drugs markets in the world.

  • Prescription Drug
  • China
  • Supply
  • Tongrentang Group
  • Zhejiang Expressway Co., Ltd.
  • IV. PRESCRIPTION DRUGS PRODUCTION AND DEMAND
  • IV. PRESCRIPTION DRUGS PRODUCTION AND DEMAND

Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) INTRODUCTION Chapter I The current market for prescription drugs in China is growing rapidly.

  • Pharmaceutical
  • Prescription Drug
  • Therapy
  • China
  • Demand

Discussion Guide List of Figures FIGURE ##.

  • Obesity
  • Prescription Drug
  • United States
  • Market Size

Pricing Details List of Figures FIGURE ##.

  • Obesity
  • Prescription Drug
  • United States
  • Market Size

Anti-Obesity Prescription Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 ##.

  • Prescription Drug
  • World
  • Demand
  • Market Shares
  • Market Size

Bayer

2631 3000 2340

Snapshot Overview – Bayer’s prescription drug sales will experience modest growth over the forecast period.

  • Prescription Drug
  • China
  • Europe
  • United States
  • Forecast

prescription pharma sales outlook ## Bristol-Myers Squibb’s regional pharma sales outlook ## Bristol-Myers Squibb’s therapy area dynamics ## Bristol-Myers Squibb’s growth drivers and resistors ## Bristol-Myers Squibb’s launch/ core/ expiry analysis ## Bristol-Myers Squibb’s pipeline

  • Prescription Drug
  • United States
  • Demand

Low back pain is very common and at one point everyone must have faced this problem.

  • Prescription Drug
  • France
  • Germany
  • Italy
  • United Kingdom

Boehringer Ingelheim

2631 3000 2340

Boehringer Ingelheim Table of Contents Company Background Company Overview SWOT Analysis Key Drug and Company Information Company Comparison Company Forecast Prescription Pharmaceuticals Sales Outlook Branded Drug Outlook Therapy Area Outlook Regional Sales Outlook Lifecycle Analysis Compan

  • Prescription Drug
  • Forecast

Regeneron

2631 3000 2340

Key themes – [##] Eylea sales will peak in 2022 as biosimilar competition begins in the US in 2023 [##] Collaboration revenue will continue to grow, driven by Dupixent and international Eylea sales.

  • Prescription Drug
  • United States
  • Forecast

Biogen

2631 3000 2340

Snapshot Overview – Biogen’s prescription pharmaceutical business will see stable performance over the medium term.

  • Prescription Drug
  • European Union
  • United States
  • Forecast

Key themes – [##] Adcetris growth is slowing due to increasing market penetration and inroads from competing products like Keytruda [##] Launch of Padcev and Tukysa will drive further growth in 2020 and beyond [##] Collaborative licensing agreements with large pharmaceutical companies provide

  • Prescription Drug
  • United States
  • Forecast

Prescription Pharmaceuticals Sales Outlook Branded Drug Outlook Launch Profile Outlook Therapy Area Outlook Regional Sales Outlook Lifecycle Analysis Company Profile Marketed and Pipeline Drugs Recent Events and Analyst Opinions Upcoming Catalysts Recent Insights Clinical Trial Overview Cli

  • Prescription Drug
  • China
  • United States
  • Forecast

Key themes – [##] Spinraza royalties will comprise the majority of Ionis’s revenues for the foreseeable future [##] Pharmaceutical business growth driven by launches of Tegsedi and Waylivra.

  • Prescription Drug

Lundbeck

2631 3000 2340

Snapshot Overview – Lundbeck’s prescription pharmaceutical sales are forecast to grow over the forecast period.

  • Prescription Drug
  • Forecast

Key themes – [##] Incyte continues to grow Jakafi volumes at a strong pace, with supplemental approvals and label expansions adding to the lifecycle management of the drug [##] Jakafi patent expiration in 2028 is a key event for Incyte as the drug will comprise a significant majority of compa

  • Prescription Drug
  • Demand
  • Forecast

Key themes – [##] Vertex is set for continued global cystic fibrosis market domination with its commercial and pipeline portfolios [##] Vertex’s cystic fibrosis franchise faces no short-to-medium-term competitive threats [##] Vertex is holding a hard line against ongoing pricing criticisms in

  • Prescription Drug
  • Forecast
  • OUTLINES THE SALES FOR IBS PRESCRIPTION DRUGS IN THE 5EU IN 2016 AND 2026.
  • OUTLINES THE SALES FOR IBS PRESCRIPTION DRUGS IN THE US IN 2016 AND 2026.

pg=##.

  • Prescription Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.

Key themes – [##] PharmaVitae expects Shire’s prescription pharmaceutical sales to grow at a ##. ##% CAGR between 2017–## [##] Shire’s CNS portfolio will increase to $##. ##bn in 2022, but then fall sharply to $##. ##bn in 2027 due to generic erosion of Vyvanse sales in the US [##] Shire’s mar

  • Prescription Drug
  • Demand
  • Prescription Drugs and Medical Insurance are the Areas of Focus for Retail Giants
  • 3.4 Alibaba Aims to Deepen Presence in O2O Prescription Drug Services

http:/ / mic. iii. org. tw/ intelligence FIGURE ## RETAIL GIANTS' STRATEGIES FOR HEALTHCARE MARKET EXPANSION LIST OF FIGURES TABLE ## OVERVIEW OF M& AS OF INTERNAT IONAL RETAIL GIANTS TABLE ## SELF-OPERATED HEALTHCARE SERVICE OF AMAZON AND WALGREENS TABLE ## RETAIL BRA

  • Prescription Drug
  • United States
  • Market Size
  • CVS Caremark Corporation
  • Walgreens Boots Alliance, Inc.

During 2016–##, Merck KGaA’s prescription pharmaceutical sales are forecast to grow by $##m as it shifts focus to Bavencio and its oncology portfolio.

  • Prescription Drug
  • Demand
  • Market Size

Highlights Bayer’s prescription drug sales will experience modest growth up to 2026.

  • Prescription Drug
  • Demand

Q## 2017 regulatory update COMPANY CONTEXT AbbVie split from Abbott Humira Amgen-AbbVie settlement Future revenue streams Commercial strategy AbbVie’s SWOT analysis AbbVie’s key events and catalysts FACTS AND FIGURES AbbVie’s prescription pharma sales outlook AbbVie’s regional pharma sales o

  • Prescription Drug
  • Demand

##: Pharmaceutical share of total healthcare spending in the US, Canada, and the five major EU markets ## Table ##: Per capita pharmaceutical spending in the US, Canada, and the five major EU markets ## Table ##: Pharmaceutical share of total healthcare spending in the US, 2000–## ## Table ##:

  • Pharmaceutical
  • Prescription Drug
  • United States

Highlights Shionogi’s prescription pharmaceutical sales are forecast to achieve modest growth.

  • Prescription Drug
  • Market Shares

Highlights Big Pharma prescription drug sales are forecast to grow to $##bn by 2026 at a compound annual growth rate of ##. ##% Number one company in 2021: Pfizer sustains top ranking in prescription drug sales out to 2021 Number one company in 2026: Roche out-perfo

  • Pharmaceutical
  • Prescription Drug
  • Demand

INTRODUCTION.............. ## ##.

  • E-Healthcare
  • Healthcare IT
  • Prescription Drug
  • United States
  • Market Shares
  • FEB 07, 2017: MONOSOL RX RECEIVES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM
  • LICENSING AGREEMENTS

The Tadalafil OSF NDA has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ##, 2017.

  • Prescription Drug
  • Therapy
  • United States
  • Company
  • MonoSol Rx, LLC
  • FEB 07, 2017: MONOSOL RX RECEIVES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM
  • LICENSING AGREEMENTS

The Tadalafil OSF NDA has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ##, 2017.

  • Prescription Drug
  • Therapy
  • United States
  • Company
  • MonoSol Rx, LLC